Total Funding
4
1
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
792444
Arocell develops and commercializes new and unique biomarker tests that can be used in the prognosis, monitoring, and follow-up of cancer.
- Martin Shaw: Business Development Manager
- Filip Fogdestam: Head of Operations
About the Company
Arocell develops and commercializes new and unique biomarker tests that can be used in the prognosis, monitoring, and follow-up of cancer. It has developed a test, the TK 210 ELISA for measuring the enzyme TK1, which is a protein that is elevated in the blood when there is increased cell turnover (cell growth and cell death) within the patient.
The company was established in 2003 and is based in Uppsala, Sweden.
